Iterum Therapeutics Balance Sheet Health
Financial Health criteria checks 0/6
Iterum Therapeutics has a total shareholder equity of $-11.5M and total debt of $22.4M, which brings its debt-to-equity ratio to -195%. Its total assets and total liabilities are $15.9M and $27.4M respectively.
Key information
-195.0%
Debt to equity ratio
US$22.44m
Debt
| Interest coverage ratio | n/a |
| Cash | US$14.50m |
| Equity | -US$11.51m |
| Total liabilities | US$27.43m |
| Total assets | US$15.92m |
Recent financial health updates
Recent updates
Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Aug 19
Iterum Therapeutics Non-GAAP EPS of -$0.03 beats by $0.03
Aug 12Iterum jumps 64% as FDA agrees to Phase 3 trial for UTI candidate
Jul 11Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
May 06Does Iterum Therapeutics (NASDAQ:ITRM) Have A Healthy Balance Sheet?
Jan 12Is Iterum Therapeutics (NASDAQ:ITRM) A Risky Investment?
Sep 25Despite Risks Around Regulatory Approval, Iterum Therapeutics Rates A Speculative Buy
Jul 05It's Unlikely That The CEO Of Iterum Therapeutics plc (NASDAQ:ITRM) Will See A Huge Pay Rise This Year
Jun 11Is Iterum Therapeutics (NASDAQ:ITRM) Using Debt Sensibly?
May 20Have Insiders Been Selling Iterum Therapeutics plc (NASDAQ:ITRM) Shares?
Feb 04This Insider Has Just Sold Shares In Iterum Therapeutics plc (NASDAQ:ITRM)
Feb 04Iterum Therapeutics shares slide 13% on raising $10M
Feb 03Iterum Therapeutics rises 39% on RA Capital stake disclosure
Dec 03Iterum Therapeutics files US application for sulopenem in urinary tract infections
Nov 30Iterum Therapeutics EPS beats by $0.45
Nov 16Financial Position Analysis
Short Term Liabilities: ITRM has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ITRM has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ITRM has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: ITRM's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ITRM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ITRM has less than a year of cash runway if free cash flow continues to grow at historical rates of 22.4% each year.